Molecule Details
InChIKeyASMXXROZKSBQIH-VITNCHFBSA-N
Compound NameAclidinium
Canonical SMILESO=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)5
Pfam Stratification Homologous
Avg pChEMBL9.77
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB08897
Drug NameAclidinium
CAS Number727649-81-2
Groups approved
ATC Codes R03BB05 R03AL05
DescriptionAclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.

Categories: Adrenergics, Inhalants Agents producing tachycardia Agents to Treat Airway Disease Alkaloids Anticholinergic Agents Antimuscarinics Antispasmodics Aza Compounds Azabicyclo Compounds Cholinesterase substrates Drugs for Obstructive Airway Diseases Drugs that are Mainly Renally Excreted Muscarinic Antagonists
Cross-references: BindingDB: 50296331 ChEBI: 65346 CHEMBL1194325 ChemSpider: 9609381 Drugs Product Database (DPD): 22129 D08837 PubChem:11434515 PubChem:175427140 RxCUI: 1303098 Wikipedia: Aclidinium_bromide ZINC: ZINC000030691727
Target Activities (5)
Target Gene Organism Category Pfam pChEMBL Type Source
P11229 CHRM1 Homo sapiens Human PF00001 10.0 IC50 ChEMBL;BindingDB
P08172 CHRM2 Homo sapiens Human PF00001 9.8 IC50 ChEMBL;BindingDB
P08912 CHRM5 Homo sapiens Human PF00001 9.8 IC50 ChEMBL;BindingDB
P08173 CHRM4 Homo sapiens Human PF00001 9.7 IC50 ChEMBL;BindingDB
P20309 CHRM3 Homo sapiens Human PF00001 9.5 IC50 ChEMBL;BindingDB
DrugBank Target Actions (6)
Target Gene Target Name Action Type
P06276 BCHE Cholinesterase substrate enzymes
P08172 CHRM2 Muscarinic acetylcholine receptor M2 antagonist targets
P08173 CHRM4 Muscarinic acetylcholine receptor M4 antagonist targets
P08912 CHRM5 Muscarinic acetylcholine receptor M5 antagonist targets
P11229 CHRM1 Muscarinic acetylcholine receptor M1 antagonist targets
P20309 CHRM3 Muscarinic acetylcholine receptor M3 antagonist targets